Kolkata: After the approval of the drug regulator, the drug controller of India (DCGI), the retailer in the city gets many questions from consumers about nitric oxide nasal spray which is likely to benefit high-risk adults suffering from covid.
Retailers expect sprays available at retail outlets in mid-February.
“We get at least 10 questions about the medicine every day.
His awareness spreads and seems to also read a lot about it,” said Rajendra Khandelwal from Dhanwantari Pharma.
“We even got questions from a doctor about the product.
DCGI recently gave his approval on the drug and we hope it will be launched soon,” he said.
Intrasal spray is expected to prevent a mild Covid-19 infection progress towards moderate or severe illness.
Peerless Hospital is one of the centers where the phase-III clinical trial of the drug is carried out to test its safety and efficacy.
“This drug will definitely become a weapon to prevent rapid disease development, reducing morbidity and mortality in high-risk groups.
During our trial, we also found some negative switch patients within 72 hours using nasal sprays,” said the clinical research of peerless hospitals and Academic Director Subhrojyoti Bhowmick, who is one of the main research researchers.
Positive patients between the ages of 25 and 55 were taken for Phase-III trials in Kolkata.
Sajal Ganguly, Secretary of Bengal chemistry and drug association (BCDA), said that retailers expect spray available in a few days.
“Based on the feedback we get from the distributor and stockist, it must contact us in a few days,” he said.
Managed through nose route, PUFF must be given to more infected patients on the OPD.
The drug regime will be two puffs from spray six times a day for 10 days.
Health experts say that this nitric oxide nasal spray by Glenmark Pharmaceuticals, India will be a cost-effective treatment.
But they warned that the drug must be used only under the supervision of Somnath Ghosh from Metro Pharma said that retailers are now looking for more clarity about sprays.
“We are not sure whether this will be a prescription drug or can be sold as an over-the-counter product.
In addition, we need a guide regarding recording buyers’ details as we did for several other drugs prescribed for Covid-19.
Overall, query About products are very encouraging in the city, “he said.